Physician profile
Crystal Kline
NPI 1295227437
$4,509.71
in general payments reported to CMS, 2019-2025
32 companies · $705 in 2025
The $705 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,010 · 2022: $1,338 · 2023: $1,366 · 2024: $91.51 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,055 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,055.41 |
| Education | $107.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,022.75 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $591.25 | 2022-2025 | |
| Corcept Therapeutics | $545.65 | 2021-2025 | Korlym |
| Abbott Laboratories | $333.93 | 2021-2025 | Freestyle Libre 2, Freestyle Libre 3, Freestyle Libre |
| Lilly USA, LLC | $261.20 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.74 | 2021-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $189.59 | 2021-2023 | Farxiga |
| Mannkind Corporation | $166.68 | 2021-2025 | |
| Dexcom, INC. | $151.08 | 2021-2024 | Dexcom G6 Transmitter |
| Abbvie INC. | $118.86 | 2021-2023 | |
| Amgen INC. | $116.55 | 2021-2025 | Prolia, Evenity, Otezla |
| Insulet Corporation | $115.13 | 2022-2025 | Omnipod |
| Novartis Pharmaceuticals Corporation | $83.01 | 2021-2022 | |
| Tandem Diabetes Care, INC. | $70.33 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Merck Sharp & Dohme LLC | $69.74 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $63.47 | 2021-2023 | Nayzilam, Briviact |
| Medtronic, INC. | $40.16 | 2021-2023 | Minimed 780g |
| Xeris Pharmaceuticals, INC. | $39.06 | 2023-2025 | Gvoke Hypopen, Keveyis |
| Recordati_rare_diseases_inc. | $38.50 | 2025 | Isturisa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.66 | 2023 | Xifaxan |
| Sequel Med Tech, LLC | $29.68 | 2025 | Twiist |
| Sanofi-Aventis U.S. LLC | $27.91 | 2021-2023 | |
| Ascensia Diabetes Care US INC. | $24.32 | 2025 | |
| Exact Sciences Corporation | $17.24 | 2024 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $17.19 | 2022 | |
| Astellas Pharma US INC | $16.78 | 2023 | Myrbetriq |
| Daiichi Sankyo INC. | $15.11 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $14.00 | 2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $13.74 | 2023 | Eliquis |
| Avanos Medical | $13.50 | 2024 | On-Q* Pump and Accessories |
| Glaxosmithkline, LLC. | $12.99 | 2023 | Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Kline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.